Drug Type lncRNA |
Synonyms- |
Target |
Mechanism MnSOD inhibitors(superoxide dismutase 2 inhibitors), YAP1 inhibitors(Yes1 associated transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | OM | 10 Mar 2024 |